- call +1-201-465-4211
- email sales@mrinsights.biz
Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
Scope of the Report:
This report studies the Dengue Virus Diagnostic Tests market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Dengue Virus Diagnostic Tests market by product type and applications/end industries.
The global Dengue Virus Diagnostic Tests market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Dengue Virus Diagnostic Tests.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Arkray
Ceres Nanosciences
Roche Diagnostics
Corgenix Medical
FK-Biotecnologia
QuantuMDx Group
Sansure Biotech
Quidel Corp
Whidiag
Pictor
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Rapid Molecular Assay
Biomarker Assay
IsoAmp Assay
Others
Market Segment by Applications, can be divided into
Hospitals
Research Institutes
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Dengue Virus Diagnostic Tests Market Overview
1.1 Product Overview and Scope of Dengue Virus Diagnostic Tests
1.2 Classification of Dengue Virus Diagnostic Tests by Types
1.2.1 Global Dengue Virus Diagnostic Tests Revenue Comparison by Types (2017-2023)
1.2.2 Global Dengue Virus Diagnostic Tests Revenue Market Share by Types in 2017
1.2.3 Rapid Molecular Assay
1.2.4 Biomarker Assay
1.2.5 IsoAmp Assay
1.2.6 Others
1.3 Global Dengue Virus Diagnostic Tests Market by Application
1.3.1 Global Dengue Virus Diagnostic Tests Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Research Institutes
1.4 Global Dengue Virus Diagnostic Tests Market by Regions
1.4.1 Global Dengue Virus Diagnostic Tests Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Dengue Virus Diagnostic Tests Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Dengue Virus Diagnostic Tests Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Dengue Virus Diagnostic Tests Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Dengue Virus Diagnostic Tests Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Dengue Virus Diagnostic Tests Status and Prospect (2013-2023)
1.5 Global Market Size of Dengue Virus Diagnostic Tests (2013-2023)
2 Manufacturers Profiles
2.1 Arkray
2.1.1 Business Overview
2.1.2 Dengue Virus Diagnostic Tests Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Arkray Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2016-2017)
2.2 Ceres Nanosciences
2.2.1 Business Overview
2.2.2 Dengue Virus Diagnostic Tests Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Ceres Nanosciences Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche Diagnostics
2.3.1 Business Overview
2.3.2 Dengue Virus Diagnostic Tests Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Diagnostics Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2016-2017)
2.4 Corgenix Medical
2.4.1 Business Overview
2.4.2 Dengue Virus Diagnostic Tests Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Corgenix Medical Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2016-2017)
2.5 FK-Biotecnologia
2.5.1 Business Overview
2.5.2 Dengue Virus Diagnostic Tests Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 FK-Biotecnologia Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2016-2017)
2.6 QuantuMDx Group
2.6.1 Business Overview
2.6.2 Dengue Virus Diagnostic Tests Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 QuantuMDx Group Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sansure Biotech
2.7.1 Business Overview
2.7.2 Dengue Virus Diagnostic Tests Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sansure Biotech Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2016-2017)
2.8 Quidel Corp
2.8.1 Business Overview
2.8.2 Dengue Virus Diagnostic Tests Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Quidel Corp Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2016-2017)
2.9 Whidiag
2.9.1 Business Overview
2.9.2 Dengue Virus Diagnostic Tests Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Whidiag Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pictor
2.10.1 Business Overview
2.10.2 Dengue Virus Diagnostic Tests Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pictor Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2016-2017)
3 Global Dengue Virus Diagnostic Tests Market Competition, by Players
3.1 Global Dengue Virus Diagnostic Tests Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Dengue Virus Diagnostic Tests Players Market Share
3.2.2 Top 10 Dengue Virus Diagnostic Tests Players Market Share
3.3 Market Competition Trend
4 Global Dengue Virus Diagnostic Tests Market Size by Regions
4.1 Global Dengue Virus Diagnostic Tests Revenue and Market Share by Regions
4.2 North America Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
4.3 Europe Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
4.5 South America Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
5 North America Dengue Virus Diagnostic Tests Revenue by Countries
5.1 North America Dengue Virus Diagnostic Tests Revenue by Countries (2013-2018)
5.2 USA Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
5.3 Canada Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
5.4 Mexico Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
6 Europe Dengue Virus Diagnostic Tests Revenue by Countries
6.1 Europe Dengue Virus Diagnostic Tests Revenue by Countries (2013-2018)
6.2 Germany Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
6.3 UK Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
6.4 France Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
6.5 Russia Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
6.6 Italy Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Dengue Virus Diagnostic Tests Revenue by Countries
7.1 Asia-Pacific Dengue Virus Diagnostic Tests Revenue by Countries (2013-2018)
7.2 China Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
7.3 Japan Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
7.4 Korea Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
7.5 India Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
8 South America Dengue Virus Diagnostic Tests Revenue by Countries
8.1 South America Dengue Virus Diagnostic Tests Revenue by Countries (2013-2018)
8.2 Brazil Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
8.3 Argentina Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
8.4 Colombia Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Dengue Virus Diagnostic Tests by Countries
9.1 Middle East and Africa Dengue Virus Diagnostic Tests Revenue by Countries (2013-2018)
9.2 Saudi Arabia Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
9.3 UAE Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
9.4 Egypt Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
9.5 Nigeria Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
9.6 South Africa Dengue Virus Diagnostic Tests Revenue and Growth Rate (2013-2018)
10 Global Dengue Virus Diagnostic Tests Market Segment by Type
10.1 Global Dengue Virus Diagnostic Tests Revenue and Market Share by Type (2013-2018)
10.2 Global Dengue Virus Diagnostic Tests Market Forecast by Type (2018-2023)
10.3 Rapid Molecular Assay Revenue Growth Rate (2013-2023)
10.4 Biomarker Assay Revenue Growth Rate (2013-2023)
10.5 IsoAmp Assay Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)
11 Global Dengue Virus Diagnostic Tests Market Segment by Application
11.1 Global Dengue Virus Diagnostic Tests Revenue Market Share by Application (2013-2018)
11.2 Dengue Virus Diagnostic Tests Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Research Institutes Revenue Growth (2013-2018)
12 Global Dengue Virus Diagnostic Tests Market Size Forecast (2018-2023)
12.1 Global Dengue Virus Diagnostic Tests Market Size Forecast (2018-2023)
12.2 Global Dengue Virus Diagnostic Tests Market Forecast by Regions (2018-2023)
12.3 North America Dengue Virus Diagnostic Tests Revenue Market Forecast (2018-2023)
12.4 Europe Dengue Virus Diagnostic Tests Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Dengue Virus Diagnostic Tests Revenue Market Forecast (2018-2023)
12.6 South America Dengue Virus Diagnostic Tests Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Dengue Virus Diagnostic Tests Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Dengue Virus Diagnostic Tests Picture
Table Product Specifications of Dengue Virus Diagnostic Tests
Table Global Dengue Virus Diagnostic Tests and Revenue (Million U
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
